Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · http://onlinelibrary.wiley.com/termsAndConditions#vor · Source: journal-auto-sync:external:CROSSREF_ISSN
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMaria J. Iuorno, John E. Nestler
Abstract
Rights: UNKNOWN · http://onlinelibrary.wiley.com/termsAndConditions#vor · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1210/jc.83.9.3078
10.1210/jc.83.9.3078
10.1210/jcem-57-2-356
10.1210/jcem-57-2-356
10.1210/jc.75.2.577
10.1210/jc.75.2.577
Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
10.2337/diab.41.10.1257 · 1992
a long‐term follow‐up focusing on natural history and circulating hormones.
1956
10.1016/s0002-9343(99)80057-6
10.1016/s0002-9343(99)80057-6
10.2337/diacare.22.1.141
10.2337/diacare.22.1.141
10.1210/jc.84.1.165
10.1210/jc.84.1.165
Role ofsulin resistance in human disease.
1988
Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: Parallels between human disease and rodent models.
10.2337/diacare.14.3.195 · 1991
10.1056/nejm198903163201105
10.1056/nejm198903163201105
10.1016/0002-9343(83)90653-8
10.1016/0002-9343(83)90653-8
10.2337/diab.37.3.262
10.2337/diab.37.3.262
10.1172/jci114745
10.1172/jci114745
10.1210/endo-123-2-733
10.1210/endo-123-2-733
10.1172/jci106628
10.1172/jci106628
10.1210/jcem-68-6-1027
10.1210/jcem-68-6-1027
10.1016/0002-9378(90)90698-7
10.1016/0002-9378(90)90698-7
10.1007/bf01263443
10.1007/bf01263443
10.7326/0003-4819-83-4-567
10.7326/0003-4819-83-4-567
10.1007/bf00562061
10.1007/bf00562061
10.1111/j.1365-2125.1981.tb01206.x
10.1111/j.1365-2125.1981.tb01206.x
Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non‐diabetic obese subjects.
10.1055/s-0038-1651126 · 1987
10.1210/jcem-73-6-1294
10.1210/jcem-73-6-1294
10.2337/diacare.10.1.62
10.2337/diacare.10.1.62
10.2337/diabetes.32.12.1083
10.2337/diabetes.32.12.1083
10.2337/diacare.13.1.1
10.2337/diacare.13.1.1
10.1136/bmj.2.6102.1576
10.1136/bmj.2.6102.1576
10.1016/0026-0495(85)90139-8
10.1016/0026-0495(85)90139-8
Metformin reduces insulin requirement in type I diabetes.
1998
10.1530/eje.0.1380269
10.1530/eje.0.1380269
Inhibition of gluconeogenesis from lactate by phenethylbiguanide in the perfused guinea pig liver.
1982
Inhibition of hepatic glucose output due to an inhibition of gluconeogenesis.
1982
10.1016/0026-0495(94)90209-7
10.1016/0026-0495(94)90209-7
10.1056/nejm199608293350902
10.1056/nejm199608293350902
10.1210/jc.82.12.4075
10.1210/jc.82.12.4075
10.1056/nejm199806253382603
10.1056/nejm199806253382603
10.1016/s0029-7844(97)00296-2
10.1016/s0029-7844(97)00296-2
10.1210/jc.80.7.2057
10.1210/jc.80.7.2057
10.1016/s0015-0282(16)58266-1
10.1016/s0015-0282(16)58266-1
10.1056/nejm199904293401703
10.1056/nejm199904293401703 · doi-reference
10.1056/nejm199008093230603
10.1056/nejm199008093230603 · doi-reference
10.1073/pnas.90.13.5924
10.1073/pnas.90.13.5924 · doi-reference
10.1016/s0015-0282(98)00454-3
10.1016/s0015-0282(98)00454-3 · doi-reference
10.1210/jc.82.7.2108
10.1210/jc.82.7.2108 · doi-reference
10.1210/jc.81.9.3299
10.1210/jc.81.9.3299 · doi-reference
Thiazolidinediones in the treatment ofsulin resistance and type 2 diabetes.
10.2337/diab.45.12.1661 · doi-reference
Troglitazone enhances differentiation, basal glucose uptake, and Glut 1 protein levels in 3T3‐L1 adipocytes.
10.1210/endo.137.11.8895337 · doi-reference
10.1210/en.133.1.352
10.1210/en.133.1.352 · doi-reference
Insulin‐like activity of new antidiabetic agent CP68722 in 3T3‐L1 adipocytes.
10.2337/diab.39.11.1414 · doi-reference
10.1056/nejm199411033311803
10.1056/nejm199411033311803 · doi-reference
10.1016/s0026-0495(97)90066-4
10.1016/s0026-0495(97)90066-4 · doi-reference
10.1046/j.1365-2796.1997.00236.x
10.1046/j.1365-2796.1997.00236.x · doi-reference
10.3109/00016349209006227
10.3109/00016349209006227 · doi-reference
10.1016/s0002-9378(11)90605-x
10.1016/s0002-9378(11)90605-x · doi-reference
10.1016/s0002-9343(99)80056-4
10.1016/s0002-9343(99)80056-4 · doi-reference
10.1046/j.1365-2796.1996.364690000.x
10.1046/j.1365-2796.1996.364690000.x · doi-reference
10.1007/bf01221950
10.1007/bf01221950 · doi-reference
10.1016/s0015-0282(98)00011-9
10.1016/s0015-0282(98)00011-9 · doi-reference
10.1210/jc.81.8.2854
10.1210/jc.81.8.2854 · doi-reference
10.1111/j.1365-2265.1993.tb02144.x
10.1111/j.1365-2265.1993.tb02144.x · doi-reference
10.2337/diab.38.9.1165
10.2337/diab.38.9.1165 · doi-reference
10.1210/jcem-65-3-499
10.1210/jcem-65-3-499 · doi-reference
10.1055/s-2007-1009245
10.1055/s-2007-1009245 · doi-reference
10.1111/j.1749-6632.1993.tb43860.x
10.1111/j.1749-6632.1993.tb43860.x · doi-reference
10.1210/jc.82.2.524
10.1210/jc.82.2.524 · doi-reference